نتایج جستجو برای: oncolysis

تعداد نتایج: 455  

2014
Michael Behr Johanna K. Kaufmann Patrick Ketzer Sarah Engelhardt Martin Mück-Häusl Pamela M. Okun Gabriele Petersen Frank Neipel Jessica C. Hassel Anja Ehrhardt Alexander H. Enk Dirk M. Nettelbeck

Adenoviral gene therapy and oncolysis would critically benefit from targeted cell entry by genetically modified capsids. This requires both the ablation of native adenovirus tropism and the identification of ligands that remain functional in virus context. Here, we establish cell type-specific entry of HAdV-5-based vectors by genetic ligand insertion into a chimeric fiber with shaft and knob do...

Journal: :International Journal of Cancer 2005

Journal: :Molecular cancer therapeutics 2005
Victor W van Beusechem Petra B van den Doel Winald R Gerritsen

Conditionally replicative adenoviruses (CRAd) are under investigation as anticancer agents. Previously, we found that the CRAd AdDelta24-p53, expressing the p53 tumor suppressor protein from its genome, more effectively killed most human cancer cells than did its parent AdDelta24. However, a minority of cancer cell lines poorly responded to the oncolysis-enhancing effect of p53. Here we show th...

2016
Lily Francis Zong Sheng Guo Zuqiang Liu Roshni Ravindranathan Julie A. Urban Magesh Sathaiah Deepa Magge Pawel Kalinski David L. Bartlett

An oncolytic poxvirus such as vvDD-CXCL11 can generate potent systemic antitumor immunity as well as targeted oncolysis, yet the antitumor effect is limited probably due to limited homing to and suppressed activity of tumor-specific adaptive immune cells in the tumor microenvironment (TME). We reasoned that a chemokine modulating (CKM) drug cocktail, consisting of IFN-α, poly I:C, and a COX-2 i...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Douglas W Sborov Gerard J Nuovo Andrew Stiff Thomas Mace Gregory B Lesinski Don M Benson Yvonne A Efebera Ashley E Rosko Flavia Pichiorri Michael R Grever Craig C Hofmeister

PURPOSE Reolysin, a proprietary isolate of reovirus type III dearing, enters and preferentially induces apoptosis of malignant cells. RAS pathway activation has been associated with more efficient reoviral infectivity and enhanced oncolysis. Reovirus is currently in advanced solid tumor phase I-II trials; no clinical trials have been conducted in patients with hematologic malignancies. EXPERI...

Journal: :Cancer research 2002
Victor W van Beusechem Petra B van den Doel Jacques Grill Herbert M Pinedo Winald R Gerritsen

Conditionally replicative adenoviruses (CRAds) hold promise as anticancer agents. Their potency depends on their replication efficiency in cancer cells and their capacity to destroy these cells by oncolysis. In this regard, a critical determinant is the capacity of CRAds to induce cell death at late stages of infection to release their progeny. One of the cell death pathways that are exploited ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید